tiprankstipranks
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
Holding STOK?
Track your performance easily

Stoke Therapeutics (STOK) Financial Statements

337 Followers

Stoke Therapeutics Financial Overview

Stoke Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.099; its P/E ratio is -5.77; Stoke Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 4.89M$ 4.83M$ 4.22M$ 2.80M$ 3.31M
Gross Profit$ 4.89M$ 4.83M$ 4.22M$ 2.80M$ 3.31M
EBIT$ -30.00M$ -25.70M$ -26.37M$ -29.59M$ -24.54M
EBITDA$ -29.46M$ -25.44M$ -25.84M$ -28.96M$ -24.03M
Net Income Common Stockholders$ -26.43M$ -25.70M$ -26.37M$ -26.96M$ -24.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 239.20M$ 281.98M$ 178.58M$ 201.39M$ 214.72M
Total Assets$ 293.32M$ 307.76M$ 205.18M$ 228.34M$ 239.89M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -239.20M$ -281.98M$ -178.58M$ -201.39M$ -214.72M
Total Liabilities$ 61.21M$ 65.05M$ 64.84M$ 68.78M$ 66.89M
Stockholders Equity$ 232.11M$ 242.71M$ 140.34M$ 159.56M$ 173.00M
Cash Flow-
Free Cash Flow$ -21.72M$ -17.52M$ -24.58M$ -20.88M$ -17.64M
Operating Cash Flow$ -21.61M$ -17.48M$ -24.57M$ -20.65M$ -17.26M
Investing Cash Flow$ -30.00M$ -88.28M$ 9.99M$ 14.77M$ 14.62M
Financing Cash Flow$ 8.16M$ 120.65M$ 1.72M$ 7.34M$ 562.00K
Currency in USD

Stoke Therapeutics Earnings and Revenue History

Stoke Therapeutics Debt to Assets

Stoke Therapeutics Cash Flow

Stoke Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis